Sophiris Bio to Present Plans for Enlarged Prostate Treatment

16 views
  • About
  • Add to
Sophiris Bio (SPHS) will present at the Stifel Healthcare Conference on September 12th to discuss the company's targeted treatment of benigh prostatic hyperplasia. The conference comes just a few weeks after the company announced it had closed its public offering to raise $65 million.

0 comments